Cargando…
Novel classifiers with clinical laboratory parameters for early detection of osteosarcoma
BACKGROUND: Osteosarcoma (OS) is one of the most common malignant bone tumors. It is essential to explore early diagnostic indicators with high sensitivity and specificity due to the rapid progression and metastasis of OS and the poor survival of metastatic OS patients. However, a few indicators of...
Autores principales: | Cao, Lin‐Lin, Chen, Zhaoming, Yue, Zhihong, Pei, Lin, Jia, Mei, Wang, Hui, Li, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246378/ https://www.ncbi.nlm.nih.gov/pubmed/31916312 http://dx.doi.org/10.1002/jcla.23189 |
Ejemplares similares
-
A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
por: Cao, Lin-Lin, et al.
Publicado: (2022) -
The Potential of Serum Exosomal hsa_circ_0028861 as the Novel Diagnostic Biomarker of HBV-Derived Hepatocellular Cancer
por: Wang, Yuanxiao, et al.
Publicado: (2021) -
DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma
por: Barenboim, Maxim, et al.
Publicado: (2021) -
Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer
por: Cao, Lin-Lin, et al.
Publicado: (2022) -
Defining Models to Classify between Benign and Malignant Adnexal Masses Using Routine Laboratory Parameters
por: Reiser, Elisabeth, et al.
Publicado: (2022)